Conference Coverage

PSYCHIATRY UPDATE 2016


 

Clinical Management of Autism Spectrum Disorders: What Happens Over Time/Borderline Intellectual Functioning
Robert L. Hendren, DO, University of California, San Francisco

Combine types of treatments, such as behavioral interventions, speech and language therapy, and pharmacotherapy, to best serve patients with autism. Evidence of effectiveness of stimulants for patients with autism is mixed; fluvoxamine and sertraline have shown improvement in aggression and social relations. Alpha-adrenergic agonists could help relieve anxiety, but studies are limited. Risperidone and aripiprazole have FDA indications for autism, but are associated with adverse effects. Several biomedical treatments, such as omega-3 fatty acids, melatonin, probiotics, vitamin D3, methyl B12, oxytocin, restrictive diets, digestive enzymes, and choline, have evidence for use in patients with autism.

Pages

Recommended Reading

FDA announces new plan to combat opioid abuse
MDedge Psychiatry
NIDA releases strategic plan to prevent, treat substance use disorders
MDedge Psychiatry
ThriveNYC could help treat and destigmatize mental, behavioral disorders
MDedge Psychiatry
Designer drug symptoms can mimic schizophrenia, anxiety, depression
MDedge Psychiatry
Opioid prescribing: An odyssey of challenges
MDedge Psychiatry
Opiate drug detox appears safe in pregnancy
MDedge Psychiatry
Pot tied to increased risk of substance use disorders, not depression or anxiety
MDedge Psychiatry
We are not ‘psychiatrists’; 'The beauty of the asylum’; Challenges with false-positive urine drug screens
MDedge Psychiatry
Marijuana tourists also visiting Colorado EDs
MDedge Psychiatry
VIDEO: How proposed patient substance use privacy rule impacts physicians
MDedge Psychiatry